Wuhan Keqian Biology Co.,Ltd. (688526.SH) Receives Approval for New Veterinary Drug Registration Certificate

Stock News2025-09-29

Wuhan Keqian Biology Co.,Ltd. (688526.SH) announced that in accordance with the "Veterinary Drug Administration Regulations" and "Veterinary Drug Registration Measures," the Ministry of Agriculture and Rural Affairs of the People's Republic of China has approved the company's application for a porcine Seneca virus disease inactivated vaccine (HB16 strain, suspension culture) as a new veterinary drug and issued a "New Veterinary Drug Registration Certificate."

Porcine Seneca virus disease is a viral infectious disease that primarily affects pigs, caused by Seneca virus A (SVA) belonging to the genus Senecavirus of the family Picornaviridae. The disease spreads mainly through contact transmission and can cause vesicular lesions on the snout and coronary band of the hooves in pigs. Clinically, it is difficult to distinguish from foot-and-mouth disease, swine vesicular disease, and vesicular stomatitis. The disease has been prevalent in countries including Canada, Brazil, and the United States.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment